Immunology and Inflammation | SRI International
This is an archived website. Go to the current SRI website

Toggle Menu

Immunology and Inflammation

Immunology sheds light on the body's responses to foreign organisms, such as viruses, bacteria, protozoa, and parasites. Researchers in SRI's Center for Immunology and Infectious Diseases develop therapeutics that manipulate immune responses, and work toward immunology drug development to treat autoimmune and infectious diseases and cancer.

The group's immunology research focuses on the roles of cells and soluble factors in regulating immunity and the transition to adaptive immune responses. Immunological assays are directed toward understanding the mechanisms of activation of dendritic cells, which are critical for the induction of primary immune responses.

To meet clients' needs at all stages of immunology drug discovery and preclinical development, SRI provides a range of immunology services, including:


monoclonal antibodies

Discovery of Tyrosine Kinase 2 Inhibitors

Novel molecular targets of several cytokines are being evaluated by SRI scientists, with the goal of designing a small-molecule drug to block responses involved in many of these inflammatory diseases.